Being at Eye Level May Benefit Clinician-Patient Interaction
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 30, 2024 -- Eye-level communication by clinicians appears beneficial compared with standing at the bedside of inpatients, according to a review published online July 17 in the Journal of General Internal Medicine.
Nathan Houchens, M.D., from the University of Michigan Medical School in Ann Arbor, and colleagues conducted a systematic literature review to identify studies evaluating clinician posture (eye level or standing) during adult inpatient (including emergency department) interactions at the bedside.
The researchers identified 14 relevant studies. Ten of these studies revealed at least one favorable outcome for clinicians who communicated at the patient's eye level, three revealed no differences in patient perceptions between standing and sitting, and one found higher patient ratings for standing clinicians. Variation was seen in both interventions and outcomes, resulting in a generally high risk of bias, and relatively low adherence to assigned posture groups.
"A more robust randomized clinical trial, aimed at removing barriers to sitting and elucidating factors that drive patients' preferences, is necessary to fully understand the impact of posture on patient outcomes," the authors write. "In the meantime, given its relative ease and potential for benefit, clinicians should consider positioning themselves at eye level when speaking with their hospitalized patients."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-31 07:15
Read more
- FDA Approves Revuforj (revumenib) for the Treatment of Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
- Breathing Dirty Air Might Raise Eczema Risks
- Get With The Guidelines-Stroke Participation Has Improved Stroke Care
- Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- Vitamin D Supplements May Lower Blood Pressure in Seniors With Overweight
- Merus Receives FDA Extension of PDUFA for Zenocutuzumab
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions